Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14733367 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL29674600 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL21539907 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL264409 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL264408 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| Water SCHEMBL29821265 | 0.99 | SLC29A1 (0.58) | SLC29A1HIF1A | |
| SCHEMBL23881920 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL31093228 | 0.92 | SLC29A1 (0.49) | SLC29A1 | |
| SCHEMBL9342970 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL9342988 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| EP-4013428-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | Ionis Pharmaceuticals, Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021030763-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2021-02-18 | — | — | WO | disclosed |